Related Experiment Video
Updated: Aug 8, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Modified HMG-CoA reductase and LDLr regulation is deeply involved in age-related hypercholesterolemia
Valentina Pallottini1, Chiara Martini, Gabriella Cavallini
1Department of Biology, University of Rome "Roma Tre", Viale Marconi 446, 00146 Rome, Italy. vpallott@uniroma3.it
Insights
Aging rats develop hypercholesterolemia due to altered regulation of cholesterol synthesis. Key proteins involved in cholesterol metabolism show changes, explaining elevated cholesterol levels in aged animals.
Area of Science:
- Biochemistry
- Gerontology
- Molecular Biology
Background:
- Aging is associated with hypercholesterolemia in rats.
- The molecular mechanisms behind altered cholesterol metabolism during aging, particularly concerning 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoAR), are not well understood.
- Data on HMG-CoAR transcription and degradation during aging are lacking.
Purpose of the Study:
- To investigate the molecular basis of age-related hypercholesterolemia in rats.
- To measure mRNA levels of HMG-CoAR and key regulatory proteins involved in cholesterol metabolism.
- To assess the levels of sterol regulatory element binding proteins (SREBPs) and related genes.
Main Methods:
- Quantification of HMG-CoAR mRNA levels.
- Measurement of regulatory proteins: SREBPs, SBP cleavage activating protein, insulin-induced gene (Insigs), low-density lipoprotein receptor (LDLr), and Caveolin 1.
- Analysis of age-related changes in these molecular components.
Main Results:
- Age-related reduction in Insigs levels was observed.
- Reduced insulin sensitivity correlated with decreased HMG-CoAR degradation rate.
- Increased levels of active SREBP-2 were found, suggesting enhanced gene transcription.
- Levels of SREBP-dependent proteins, LDLr and Caveolin 1, were also measured.
Conclusions:
- Reduced Insigs levels and insulin sensitivity contribute to decreased HMG-CoAR degradation and increased active SREBP-2 in aging rats.
- Active SREBP-2 plays a significant role in age-related gene transcription.
- These findings provide insights into the molecular mechanisms underlying age-related hypercholesterolemia.
Abstract:
During the ageing process in rats hypercholesterolemia occurs in concert with full activation, lowered degradation rate and an unchanged level of the rate limiting cholesterol biosynthesis enzyme, 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoAR). The molecular bases of the HMG-CoAR unchanged level and lowered degradation rate in aged rats is not clear. In fact no data are available during ageing, on transcription and degradation of HMG-CoAR, so well defined in adult animal. So, aim of this work was to measure mRNA levels of the enzyme and the level of the proteins of the regulatory complex responsible of the cholesterol metabolism. To complete the picture, the level of sterol regulatory element binding proteins (SREBPs), SREBP cleavage activating protein, and insulin-induced gene has been measured. The levels of other related proteins, whose transcription is SREBP dependent, that is low density lipoprotein receptor (LDLr) and Caveolin 1, have been also measured. The age-related reduced Insigs levels, joined to a reduced insulin sensitivity, could explain the decreased degradation rate of the HMG-CoAR and the increased active SREBP-2. The SREBP-2 in particular seems to be committed in multiple way to gene transcription. The obtained data represent a good contribution to explain the age-related hypercholesterolemia.
More Related Videos
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
10:56A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Inflammation
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Lipids: Dietary Sources and Requirements